Drug Type Monoclonal antibody |
Synonyms- |
Target |
Action modulators |
Mechanism PCSK9 modulators(Proprotein convertase subtilisin kexin type 9 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Phase 1 | China | - | |
Metabolic Diseases | Phase 1 | China | - |